EVis Bioscience

Pre-Seed
evisbioscience.com Biotech & Healthcare Schlieren, Switzerland
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced Feb 23, 2026
Investors Undisclosed
Decision Makers Profile Active

About EVis Bioscience

EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Schlieren, Switzerland
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website evisbioscience.com
Domain Registered Date Aug 20, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Pre-Seed announced

  2. Milestone

    Website domain registered

    evisbioscience.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for EVis Bioscience.

Funding History

1 Round
Pre-Seed equity · Feb 23, 2026
Undisclosed

Founders & Leadership

3

Elita Montanari

Co-founder & CTO

Work email & phone locked Unlock →

Gianfranco Vento

Founder

Work email & phone locked Unlock →

Tommaso Caselli

Co-founder & CCO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts